PATENT CLAIM ANALYSIS

Application Number: 15748284
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The novel synergistic combination of immune checkpoint blockade and hematopoietic stem cell transplantation and/or hematopoietic stem cell mobilization yield synergistic effects in disease therapy.

Claim (Index 56):
A method for treating a disease selected from cancer or an infectious disease in a subject receiving immune checkpoint inhibitor therapy for the disease, comprising administering to the subject hematopoietic stem cells in an amount which, in combination with the immune checkpoint inhibitor therapy, is effective to treat the disease.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.19048
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14021353', '15170284', '14158531', '16068816', '15024396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7219616321856955
- 35 USC 102 Novelty (BERT): 0.5394793433424638
- Combined Prediction Score: 0.7037134033013723
- Mean Citation Score: 364.48628
- Max Citation Score: 390.14835
- Similarity Product: 329.37117278572623

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test